Risk factors for fluorouracil-induced cardiotoxicity in patients with gastrointestinal tumor
ObjectiveTo explore the risk factors for cardiotoxicity in patients with gastrointestinal (GI) tumors treated with fluorouracil drugs.MethodsThis study included patients with GI tumors who received fluorouracil at our hospital between January 2018 and April 2022. The demographic and clinical charact...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1515509/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832539892557545472 |
---|---|
author | Yuting Wu Chen Lv Jindong Li Ying Ma Xiaoli Zhu |
author_facet | Yuting Wu Chen Lv Jindong Li Ying Ma Xiaoli Zhu |
author_sort | Yuting Wu |
collection | DOAJ |
description | ObjectiveTo explore the risk factors for cardiotoxicity in patients with gastrointestinal (GI) tumors treated with fluorouracil drugs.MethodsThis study included patients with GI tumors who received fluorouracil at our hospital between January 2018 and April 2022. The demographic and clinical characteristics were collected. The risk factors associated with the cardiotoxicity of fluorouracil were explored using multivariable logistic regression.ResultsA total of 300 patients were finally included and divided into the cardiotoxicity (n = 81) and non-cardiotoxicity groups (n = 219). The occurrence of fluorouracil-induced cardiotoxicity was higher in patients with hypertension, hyperlipidemia, diabetes mellitus, older age, those treated with capecitabine, and combined radiotherapy. The multivariable logistic regression showed that treatment with capecitabine, history of hyperlipidemia, history of diabetes, older age, and combined radiotherapy were independent risk factors for the cardiotoxicity of fluorouracil.ConclusionHyperlipidemia, diabetes, older age, treatment with capecitabine, and adjuvant radiotherapy might be independent risk factors for the cardiotoxicity of fluorouracil in patients with GI tumors. |
format | Article |
id | doaj-art-513f3225d7664b0688c5c8ad9f2a13de |
institution | Kabale University |
issn | 2297-055X |
language | English |
publishDate | 2025-02-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Cardiovascular Medicine |
spelling | doaj-art-513f3225d7664b0688c5c8ad9f2a13de2025-02-05T07:32:35ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2025-02-011210.3389/fcvm.2025.15155091515509Risk factors for fluorouracil-induced cardiotoxicity in patients with gastrointestinal tumorYuting Wu0Chen Lv1Jindong Li2Ying Ma3Xiaoli Zhu4Department of Pharmacy, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, Jiangsu, ChinaDepartment of Medical Oncology, The People’s Hospital of Hengshui, Hengshui, Hebei, ChinaDepartment of Pharmacy, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, Jiangsu, ChinaDepartment of Pharmacy, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, Jiangsu, ChinaDepartment of Pharmacy, The People’s Hospital of Hengshui, Hengshui, Hebei, ChinaObjectiveTo explore the risk factors for cardiotoxicity in patients with gastrointestinal (GI) tumors treated with fluorouracil drugs.MethodsThis study included patients with GI tumors who received fluorouracil at our hospital between January 2018 and April 2022. The demographic and clinical characteristics were collected. The risk factors associated with the cardiotoxicity of fluorouracil were explored using multivariable logistic regression.ResultsA total of 300 patients were finally included and divided into the cardiotoxicity (n = 81) and non-cardiotoxicity groups (n = 219). The occurrence of fluorouracil-induced cardiotoxicity was higher in patients with hypertension, hyperlipidemia, diabetes mellitus, older age, those treated with capecitabine, and combined radiotherapy. The multivariable logistic regression showed that treatment with capecitabine, history of hyperlipidemia, history of diabetes, older age, and combined radiotherapy were independent risk factors for the cardiotoxicity of fluorouracil.ConclusionHyperlipidemia, diabetes, older age, treatment with capecitabine, and adjuvant radiotherapy might be independent risk factors for the cardiotoxicity of fluorouracil in patients with GI tumors.https://www.frontiersin.org/articles/10.3389/fcvm.2025.1515509/fullfluorouracil drugschemotherapygastrointestinal neoplasmscardiotoxicityrisk factors |
spellingShingle | Yuting Wu Chen Lv Jindong Li Ying Ma Xiaoli Zhu Risk factors for fluorouracil-induced cardiotoxicity in patients with gastrointestinal tumor Frontiers in Cardiovascular Medicine fluorouracil drugs chemotherapy gastrointestinal neoplasms cardiotoxicity risk factors |
title | Risk factors for fluorouracil-induced cardiotoxicity in patients with gastrointestinal tumor |
title_full | Risk factors for fluorouracil-induced cardiotoxicity in patients with gastrointestinal tumor |
title_fullStr | Risk factors for fluorouracil-induced cardiotoxicity in patients with gastrointestinal tumor |
title_full_unstemmed | Risk factors for fluorouracil-induced cardiotoxicity in patients with gastrointestinal tumor |
title_short | Risk factors for fluorouracil-induced cardiotoxicity in patients with gastrointestinal tumor |
title_sort | risk factors for fluorouracil induced cardiotoxicity in patients with gastrointestinal tumor |
topic | fluorouracil drugs chemotherapy gastrointestinal neoplasms cardiotoxicity risk factors |
url | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1515509/full |
work_keys_str_mv | AT yutingwu riskfactorsforfluorouracilinducedcardiotoxicityinpatientswithgastrointestinaltumor AT chenlv riskfactorsforfluorouracilinducedcardiotoxicityinpatientswithgastrointestinaltumor AT jindongli riskfactorsforfluorouracilinducedcardiotoxicityinpatientswithgastrointestinaltumor AT yingma riskfactorsforfluorouracilinducedcardiotoxicityinpatientswithgastrointestinaltumor AT xiaolizhu riskfactorsforfluorouracilinducedcardiotoxicityinpatientswithgastrointestinaltumor |